Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biotalys NVFRA:86C +3.39%39 EBIT per Share is €-0.42 as of Dec. 2025. GuruFocus rates FRA:86C with a GF Score™ of 39/100. The stock has 1 warning sign investors should review. Among 217 Agriculture companies, Biotalys NV ranks better than 82.03% on this metric.
Biotalys NV's EBIT per Share for the
six
months ended in Dec. 2025 was €-0.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.42.
During the past 3 years, the average EBIT per Share Growth Rate was 16.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 9.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Biotalys NV's EBIT per Share or its related term are showing as below:
FRA:86C'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -33.3 Med: 1.1 Max: 29.8
Current: 16.6
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Biotalys NV was 29.80% per year. The lowest was -33.30% per year. And the median was 1.10% per year.
FRA:86C's 3-Year EBIT Growth Rate is ranked better than 82.03% of 217
companies
in the Agriculture industry
Industry Median: -5.8
vs FRA:86C: 16.60
Biotalys NV's EBIT for the
six
months ended in Dec. 2025 was €-7.80 Mil.
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Biotalys NV EBIT per Share Related Terms
Biotalys NV EBIT per Share Historical Data
* Premium members only.
The historical data trend for Biotalys NV's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotalys NV (FRA:86C) has a EBIT per Share of €-0.42 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Biotalys NV and its competitors. According to the industry distribution chart, Biotalys NV ranks #39 out of 217 companies in the Agriculture industry, placing it in the top 18%.
Is Biotalys NV's EBIT per Share too high?
Biotalys NV's current EBIT per Share is €-0.42. Based on the distribution chart, Biotalys NV ranks #39 out of 217 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Biotalys NV has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Biotalys NV's EBIT per Share compare to CTVA and CF?
According to the Agriculture industry distribution chart, Biotalys NV ranks #39 out of 217 companies for EBIT per Share. This places Biotalys NV in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Agriculture company?
A good EBIT per Share depends on the Agriculture industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Biotalys NV and its competitors. Biotalys NV's current EBIT per Share is €-0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotalys NV stock overvalued right now?
Biotalys NV (FRA:86C) has a current EBIT per Share of €-0.42. The current EBIT per Share is €-0.42. Biotalys NV's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Biotalys NV (FRA:86C), the current EBIT per Share is €-0.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins for the protection of crops in both the pre and post harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Its pipeline EVOCA 1st Gen, EVOCA NG, BioFun-6, and BioFun-7. It operates in single segment.
39GF Score
Get the complete analysis for FRA:86C
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:86C has been successfully added to your 
